Dr. Gomella on Screening Recommendations in Prostate Cancer

Video

In Partnership With:

Leonard G. Gomella, MD, discusses recommendations for screening in prostate cancer.

Leonard G. Gomella, MD, professor, chair of the Department of Urology, and director of the Sidney Kimmel Cancer Center Network, of Thomas Jefferson University Hospital, discusses recommendations for screening in prostate cancer.

Men with known BRCA1/2 mutations or DNA repair pathway gene mutations should consider being screened earlier than men in the general population, says Gomella.

Currently, widespread genetic testing is not available in prostate cancer, explains Gomella. However, men with a family history of hereditary breast, ovarian, or advanced prostate cancers should consider germline genetic testing.

While genetic testing is not the standard of care, the National Comprehensive Cancer Network guidelines recommend screening for patients with these risk factors, concludes Gomella.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD